Deep Groin Pain When You Stand Up: Why the Hip Joint Is So Often the Source

What this video covers

• Why researchers think hip osteoarthritis pain involves synovial inflammation and nerve sensitization, not cartilage wear alone
• How corticosteroid placed inside the joint capsule is thought to reduce inflammatory signaling and quiet pain
• Why the hip is too deep to inject reliably by feel, and how ultrasound or fluoroscopy with contrast confirms the needle is actually inside the joint
• What the evidence really shows: pain reduction measured out to about twelve weeks in pooled trials, which is where follow-up stopped — many patients get less, some get none, and no injection has been shown to slow the arthritis itself
• How the anesthetic portion is used to help localize, not prove, whether the hip joint or the lumbar spine and outer-hip structures generate the pain
• The material risks: post-injection flare, facial flushing, a temporary blood-sugar rise that matters if you are diabetic, skin or fat thinning at the site, bleeding, fainting, rare joint.
• MEDICAL DISCLAIMER: This content is for educational purposes only and is not medical advice. It does not substitute for professional diagnosis or treatment. Always consult a licensed healthcare provider regarding your condition. Viewing this video does not establish a doctor-patient relationship.

You swing your leg out of the car, put your foot on the pavement, and something deep catches. It sits in the groin and slides down the front of the thigh toward the knee. When someone asks you to point to it, you cannot. Instead you cup your hand around the side of the hip — thumb into the crease at the front, fingers back toward the buttock. By the end of a shift you are limping and pretending you are not.

That hand position has a name: the C-sign. When a patient makes that shape unprompted, the hip joint itself moves to the top of the list. It is a strong clue, not a diagnosis — everything that follows is a test of it. This article explains what is happening inside an arthritic hip, why it produces exactly that pattern of pain, why the workup so often goes to the lumbar spine first, and what that means for how you should be evaluated.

Not simply wearing out: the case that an arthritic hip is chemically irritated

Hip osteoarthritis is usually taught as wear, as though cartilage were a brake pad you used up. That model does not explain a well-described discordance: radiographic severity and pain severity track each other poorly. Some badly narrowed hips walk comfortably. Some hips with modest changes on film cannot sleep.

Laboratory work suggests the joint is not passively wearing out. Cartilage debris shed into the joint space appears to activate synovial macrophages — immune cells resident in the joint lining. Those cells are believed to release interleukin-1 beta, tumor necrosis factor alpha, and matrix metalloproteinases: a signal set that digests remaining cartilage matrix and sensitizes nerve endings in the capsule and in the subchondral bone just beneath the joint surface.

The hedged verbs in that paragraph are deliberate. Much of this comes from tissue and animal work. It is a hypothesis about human hip pain, not proven human causation, and it will not be presented here as anything more.

But if it is right, part of what you feel is not geometry at all. It is inflammatory signaling inside a closed compartment — which is a different problem, with different options, than a mechanical one. That inference is also the entire rationale for placing corticosteroid, usually together with a local anesthetic, inside the joint capsule, where it is thought to blunt that signaling.

Why an arthritic hip produces groin and thigh pain you cannot point to

The hip is a deep ball-and-socket joint buried beneath the iliopsoas tendon. Its capsule and the bone underneath it carry the nerve endings that are thought to become sensitized, and those nerves refer pain forward and down — into the groin, across the front of the thigh, sometimes as far as the knee. Nothing about that territory feels like “the hip” to a patient, because the part you can touch on the outside of your leg is not the joint.

That explains the three things people describe most often:

• It catches when the joint is loaded through rotation. Pivoting out of a car seat and rising from a low chair each rotate the femoral head inside the socket.
• You cannot localize it, so you cup it. The C-sign is what a hand does when the source is deep and central rather than on the surface.
• It is worse by the end of the day. By the end of a shift, many people are limping and pretending they are not.

And whatever the mechanism turns out to be, the discordance stands on its own: a hip can hurt severely on a film that looks unimpressive, and a frightening-looking film can belong to someone who walks fine.

What the standard workup often misses

None of this is anyone’s negligence. It is a genuinely hard differential, and the overlap is unforgiving.

Groin and front-of-thigh pain gets read as a back problem, because the low lumbar nerve roots refer into exactly that territory. So the lumbar MRI gets ordered — and in an adult over fifty, a lumbar MRI is almost never clean. A disc gets circled, an epidural gets scheduled, and nothing changes, because nothing was wrong there in the first place.

The other common path is the hip film that shows joint-space loss, followed by advice to come back when it is bad enough to replace. Waiting is not a treatment plan. It sends people home to stop walking and lose exactly the abductor strength that recovery requires.

And when an injection is finally offered, it is often done by feel — surface landmarks, no imaging. The hip sits deep, with the femoral nerve, artery, and vein just medial to the needle path. Steroid left in the fat outside the capsule is not a hip injection.

This is not a matter of opinion. A 2016 systematic review and meta-analysis by Hoeber and colleagues in the British Journal of Sports Medicine found needle-placement accuracy of 98 to 100 percent with ultrasound guidance, against 72 percent using surface landmarks alone.¹ More than one in four blind attempts put the drug somewhere other than inside the joint, and the confidence interval around that landmark figure is wide (56 to 85 percent). Two cautions belong with that number: it measures where the needle ended up, not whether the patient felt better, and the review compared ultrasound against landmarks only — it did not include a fluoroscopy arm.

What this means for your evaluation

Before anything is injected, the question the referral skipped has to be answered: is this the hip joint, the lumbar spine, or something outside the hip?

Sorting the four usual suspects

• Intra-articular hip pain is anterior, deep, and provoked by rotation.
• Greater trochanteric pain syndrome — gluteal tendinopathy more often than true bursitis — hurts on the outside of the hip and when you lie on that side.
• Sacroiliac pain sits below the belt line, behind.
• Lumbar radiculopathy refers from the spine into overlapping territory, which is why it is so often blamed first.

In younger hips, labral tear and femoroacetabular impingement enter the picture — and the injection evidence there is thinner than it is in osteoarthritis, which is worth saying out loud before anything is booked. Avascular necrosis of the femoral head must also stay on the list, because it changes management entirely.

The examination comes before the imaging

Two maneuvers do most of the work: testing internal rotation with the hip flexed, and log-rolling the fully relaxed leg. The log roll matters because it rotates the femoral head inside the socket while stressing almost nothing outside the joint. Imaging follows the examination, not the reverse.

When the picture stays mixed

In an adult who has both spinal and hip degeneration, the picture usually stays mixed. That is where the local anesthetic portion of an image-guided hip joint injection becomes an information-gathering tool: if it substantially quiets your pain while it lasts, the hip becomes the leading suspect.

Two honest qualifications. Using an anesthetic this way is off-label — common in interventional pain medicine, but not an FDA-approved indication. And a single block can be falsely positive. It helps localize. It does not prove.

What the injection evidence actually shows

A 2020 systematic review and meta-analysis by Zhong and colleagues in BioMed Research International pooled twelve trials of intra-articular steroid injection for hip osteoarthritis and reported statistically significant pain reduction out to twelve weeks.² Read that with its limitations attached:

• Those twelve trials mixed randomized studies with uncontrolled, open-label ones, a design mix that tends to inflate apparent benefit.
• Twelve weeks is where follow-up stopped. It is a ceiling on what was measured, not a promise of duration.
• The result is statistical significance in pooled data, not a guarantee that any given person clears a threshold they would call meaningful.
• Nothing here shows the injection slows the arthritis itself. Many patients get less. Some get nothing. Individual results vary.

Who this is actually for — and who it is not for

Candidates are adults with hip osteoarthritis visible on film who have already given activity modification, physical therapy, weight management, and analgesics an honest trial and are still not getting enough relief. It is not a first move.

It is not appropriate at all with an active infection anywhere in the body, or with bleeding risk that cannot be controlled. Bring a complete list of anticoagulants, including anything bought over the counter.

The risks, named plainly

A flare in the first day or two. Facial flushing. A temporary rise in blood sugar, which matters if you are diabetic. Thinning of skin or fat at the injection site. Bleeding. Fainting. Rarely, infection inside the joint. When fluoroscopy is used, contrast reaction and radiation exposure. Repeated steroid can suppress adrenal output, and repeated corticosteroid or intra-articular anesthetic raises concern about cartilage toxicity.

Between that concern and cumulative steroid load, injections are generally limited to roughly three to four per joint per year. That figure is a practice convention, not a validated threshold.

A 2023 systematic review and meta-analysis by Sabatini and colleagues in Arthroplasty Today pooled a six percent incidence of rapidly progressive osteoarthritis after intra-articular hip corticosteroid injection.³ The authors’ own caveats travel with that number and must not be dropped: the true incidence is unknown because definitions and follow-up varied across studies, many cases were not severe, and causation is not established. Femoral head collapse appears in case reports only, with no reliable rate attached.

If a hip replacement is already scheduled within roughly three months, our practice defers injection out of concern about infection around a new implant. That is a clinic policy based on that concern, not a finding from the studies above — so tell us the surgical date.

What a plausible course looks like

The following is a composite — a picture assembled from many patients with this condition, not one person’s chart. It is one plausible course, and it has deliberately not been made the best one.

Groin and front-of-thigh pain for two years. Two lumbar epidurals that did nothing, because the spine was never the source. Internal rotation profoundly limited; log-rolling the leg reproduced the exact pain. Radiographs showed joint-space loss. The needle was placed under ultrasound into the anterior capsular recess, and anesthetic with corticosteroid was injected. Within twenty minutes, pain present for two years was measurably quieter — which did not prove the hip, since a single block can read falsely positive, but combined with the exam and the film made it the leading suspect.

Then the honest part. Day two was worse: the post-injection flare that had been warned about. Real relief began around day four. It held about six weeks, then faded. Many patients get less than that. Some get nothing, and there is no way to tell you in advance which you will be. Individual results vary.

What mattered was the work done inside that window — abductor strengthening, gait retraining, load management, weight reduction.

And a limit worth naming: no controlled trial shows that ketogenic eating, an omega-3 pro-resolving mediator, or a red-light panel changes hip cartilage, joint-space width, or a hip pain score. In this setting those things support the rehabilitation and the weight target inside the window. They are not treatment for the arthritis. Similarly, hyaluronic acid (viscosupplementation) is FDA-approved for the knee, not the hip — using it in the hip is off-label — and platelet-rich plasma for the hip is investigational.

The injection does not cure the arthritis. Nothing injected does. It can buy a quiet window, and what happens inside that window is what changes the year.

Frequently asked questions

Key takeaways

• Deep groin and front-of-thigh pain that you cup rather than point to — the C-sign — points toward the hip joint itself, not the lower back.
• Laboratory work suggests hip osteoarthritis pain involves synovial inflammation sensitizing the capsule and subchondral bone, not cartilage wear alone; that remains a hypothesis drawn largely from tissue and animal work, not proven human causation.
• Radiographic severity and pain severity track each other poorly in both directions, which is why an unimpressive film does not settle anything.
• The hip is too deep to inject reliably by feel: needle placement was 98 to 100 percent accurate with ultrasound versus 72 percent by landmark — a measure of needle position, not of pain relief.
• Pooled trials showed statistically significant pain reduction out to twelve weeks, the limit of follow-up, from studies that mixed randomized with uncontrolled open-label designs; no injection has been shown to slow the arthritis. Individual results vary.
• Get the source of the pain identified before accepting any procedure — an examination first, imaging second, and an honest account of what the injection can and cannot do.

Medically reviewed by Gurpreet Singh Padda, MD — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. If deep groin pain is dictating how you get out of a chair, call (314) 481-5000 or text (314) 886-5902 to request an appointment — and bring your imaging.

References

1. Zhong HM, Zhao GF, Lin T, Zhang XX, Li XY, Lin JF, Zhao SQ, Pan ZJ. Intra-Articular Steroid Injection for Patients with Hip Osteoarthritis: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:6320154. PMID 32185212. PubMed
2. Hoeber S, Aly AR, Ashworth N, Rajasekaran S. Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: a systematic review and meta-analysis. Br J Sports Med. 2016;50(7):392-396. PMID 26062955. PubMed
3. Sabatini FM, Cohen-Rosenblum A, Eason TB, Hannon CP, Mounce SD, Krueger CA, Gwathmey FW, Duncan ST, Landy DC. Incidence of Rapidly Progressive Osteoarthritis Following Intra-articular Hip Corticosteroid Injection: A Systematic Review and Meta-Analysis. Arthroplast Today. 2023;24:101242. PMID 37941925. PubMed

Dr. Gurpreet Singh Padda, MD, MBA, MHP